Recent Finacing
Recent Raise
Euroscreen develops GPCR-targeted small-molecule therapeutics for women's health—advancing oral candidate ESN364 in Phase II trials for menopausal hot flashes, endometriosis, PCOS and uterine fibroids, and collaborating with pharma partners.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors